W
Wael Garas
Publications - 1
Citations - 288
Wael Garas is an academic researcher. The author has contributed to research in topics: Randomized controlled trial & Clinical endpoint. The author has an hindex of 1, co-authored 1 publications receiving 37 citations.
Papers
More filters
Journal ArticleDOI
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study
Jennifer M. Mitchell,Michael P. Bogenschutz,Alia Lilienstein,Charlotte Harrison,Sarah Kleiman,Kelly Parker-Guilbert,Marcela Ot’alora G.,Wael Garas,Casey Paleos,Ingmar Gorman,Christopher R. Nicholas,Michael C. Mithoefer,Shannon Carlin,Bruce Poulter,Ann T Mithoefer,Sylvestre Quevedo,G. M. Wells,Sukhpreet S. Klaire,Bessel A. van der Kolk,Keren Tzarfaty,Revital Amiaz,Ray Worthy,Scott Shannon,Joshua D. Woolley,Cole Marta,Yevgeniy Gelfand,Emma Hapke,Simon Amar,Yair Wallach,Randall Brown,Scott Hamilton,Julie B. Wang,Allison R. Coker,Rebecca Matthews,Alberdina de Boer,Berra Yazar-Klosinski,Amy Emerson,Rick Doblin +37 more
TL;DR: A randomized, double-blind, randomized, placebo-controlled, multi-site phase 3 clinical trial (NCT03537014) was conducted to test the efficacy and safety of 3,4-methylenedioxymethamphetamine (MDMA)-assisted therapy for the treatment of patients with severe PTSD, including those with common comorbidities such as dissociation, depression, a history of alcohol and substance use disorders, and childhood trauma as discussed by the authors.